Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
15:28
A 37-year-old woman was detained after causing an accident on the E85, having a blood alcohol level of 3.12 g/l
15:17
Transporters are requesting the replacement of the temporary compensation of the excise duty on diesel with a permanent mechanism
15:08
PPC blue, the electric mobility division of the PPC group in Romania, launches the campaign 'Charge and Win', encouraging electric vehicle drivers to shift charging outside of peak hours.
15:06
The El Niño phenomenon could push 49 million people into acute hunger by the end of next year.
15:05
North Korea threatens Japan with new military options
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
.webp)
